Search by Drug Name or NDC

    NDC 00024-5855-30 Avalide 12.5; 150 mg/1; mg/1 Details

    Avalide 12.5; 150 mg/1; mg/1

    Avalide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by sanofi-aventis U.S. LLC. The primary component is HYDROCHLOROTHIAZIDE; IRBESARTAN.

    Product Information

    NDC 00024-5855
    Product ID 0024-5855_dda07a5c-1081-495d-a4ba-f2794baaa729
    Associated GPIs 36994002300320
    GCN Sequence Number 041234
    GCN Sequence Number Description irbesartan/hydrochlorothiazide TABLET 150-12.5MG ORAL
    HIC3 A4I
    HIC3 Description ANGIOTENSIN RECEPTOR ANTAG.-THIAZIDE DIURETIC COMB
    GCN 11042
    HICL Sequence Number 018963
    HICL Sequence Number Description IRBESARTAN/HYDROCHLOROTHIAZIDE
    Brand/Generic Brand
    Proprietary Name Avalide
    Proprietary Name Suffix n/a
    Non-Proprietary Name irbesartan and hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 12.5; 150
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
    Labeler Name sanofi-aventis U.S. LLC
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020758
    Listing Certified Through 2024-12-31

    Package

    NDC 00024-5855-30 (00024585530)

    NDC Package Code 0024-5855-30
    Billing NDC 00024585530
    Package 30 TABLET, FILM COATED in 1 BOTTLE (0024-5855-30)
    Marketing Start Date 2013-01-01
    NDC Exclude Flag N
    Pricing Information N/A